Literature DB >> 1550677

Mini-Oct and Oct-2c: two novel, functionally diverse murine Oct-2 gene products are differentially expressed in the CNS.

A S Stoykova1, S Sterrer, J R Erselius, A K Hatzopoulos, P Gruss.   

Abstract

We report that two novel alternatively spliced products of the murine Oct-2 gene encode Mini-Oct (Oct-2d), a protein consisting of almost only the POU domain, and Oct-2c, a protein lacking the last 12 amino acids of Oct-2a. Ectopic expression in HeLa cells shows that Oct-2c is a transactivator, whereas Mini-Oct fails to transactivate if the octamer motif is in a promoter position next to TATA box. Mini-Oct can repress the transcriptional signal generated by endogenous octamer factors in F9 cells. It seems that Mini-Oct has the potential to serve as a transcriptional modulator for genes regulated by different octamer-binding factors. In situ hybridization reveals that Mini-Oct expression follows the general pattern of other known Oct-2 transcripts. However, it is absent from the Purkinje cell layer in the cerebellum of adult mice, and strong expression is observed in the developing nasal neuroepithelium and primary spermatids. Differential expression patterns of the Oct-2 transcripts with different transactivation/repression capacities of the encoded proteins may have a specific role in gene expression in the developing nervous system and in adult brain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1550677     DOI: 10.1016/0896-6273(92)90282-i

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  24 in total

1.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

2.  Reduced fertility in mice deficient for the POU protein sperm-1.

Authors:  R V Pearse; D W Drolet; K A Kalla; F Hooshmand; J R Bermingham; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Alternative splicing of the Brn-3a and Brn-3b transcription factor RNAs is regulated in neuronal cells.

Authors:  Y Z Liu; S J Dawson; D S Latchman
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  The different alternatively spliced isoforms of the Oct-2 transcription factor repress the involucrin promoter in a cell type-specific manner.

Authors:  C M Chapman; D S Latchman
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

5.  The ability of POU family transcription factors to activate or repress gene expression is dependent on the spacing and context of their specific response elements.

Authors:  S J Dawson; Y Z Liu; B Rodel; T Möröy; D S Latchman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 6.  POU-domain gene expression during spermatogenesis.

Authors:  A Zini; A Mielnik; P N Schlegel
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

7.  Adjacent proline residues in the inhibitory domain of the Oct-2 transcription factor play distinct functional roles.

Authors:  Y Z Liu; I K Lee; I Locke; S J Dawson; D S Latchman
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

8.  The inhibitory domain in the Oct-2 transcription factor represses gene activity in a cell type-specific and promoter-independent manner.

Authors:  K A Lillycrop; D S Latchman
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

9.  Functional characterization of the cis-regulatory elements of the rat ribophorin I gene.

Authors:  A K Rajasekaran; Z Zhou; K Prakash; G Das; G Kreibich
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

10.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.